Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!

Daniel R. van Langenberg, Abhinav Vasudevan

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1028-1029
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Issue number9
Publication statusPublished - 1 Nov 2018

Cite this